Year in Review: 10 Important Clinical Research Discoveries in 2019
As we approach the end of 2019, learn about some of the biggest advances in clinical research made this year at MSK.
Related Articles
Gerstner Sloan Kettering Graduate Students Receive 2024-2025
Nine GSK PhD students were awarded competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation (NSF).
MSK Awards and Appointments September 2024
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:
Phase II Trial of Proton Re-Irradiation+/-Chemotherapy in Previously Irradiated Recurrent Head/Neck Cancer
To report the results of a multi-center phase II trial of using proton re-irradiation (re-RT) for previously irradiated recurrent head/neck cancer (HNC).
Top doctors talk what to know about breast cancer
A panel of top doctors in the field answers questions from a group of breast cancer survivors, thrivers and caregivers.
The Olayan Center for Cancer Vaccines at MSK
Pioneering science and transformative clinical trials to accelerate precision vaccines as the next breakthrough cancer therapy.
Resolution Revolution: How a New Microscope Is Offering MSK Scientists
How cryo-electron microscopy is providing scientists at MSK with an unprecedented view of the wild and wiggly microcosm inside our cells.
Medical Gaslighting Is Real—Here’s How to Recognize It and Respond
When you’re dealing with pain or other symptoms, not being taken seriously can be a real gut punch.
MSK Researchers Report Exciting Cancer Research Advances at ESMO
Memorial Sloan Kettering Cancer Center (MSK) experts shared the results from cutting-edge advances in cancer research at the European Society of Medical Oncology (ESMO) Congress…
2024 GSK Chairman’s Prize Recognizes Renhe Luo for Research on Gene
Read about the research of Renhe Luo, winner of the 2024 GSK Chairman’s Prize, who studies gene enhancers.
MSK Research Highlights September 18, 2024
New MSK research uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian…